Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KAT2A | Q92830 | 3/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11157363 | 0.89 | CES2 (0.38) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL11460849 | 0.87 | CES2 (0.43) | MAPTALOX5CES2 | |
| SCHEMBL11470056 | 0.85 | CES2 (0.46) | MAPTALOX5CES2 | |
| SCHEMBL112481 | 0.83 | MAPT (0.34) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL15681492 | 0.83 | MAPT (0.34) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL4462202 | 0.82 | MAPT (0.33) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL7769389 | 0.79 | MAPT (0.34) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL11691086 | 0.77 | KAT2A (0.30) | MAPTKAT2A | |
| SCHEMBL11148288 | 0.74 | MAPT (0.31) | MAPTKDM4ETP53MAPK1CYP2C19 | |
| SCHEMBL4411371 | 0.74 | MAPT (0.31) | MAPTKDM4ETP53MAPK1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115738059-A | Microneedle patch with composite coating and preparation method and application thereof | 广州瑞乐科技有限公司 | 2023-03-07 | — | — | CN | claimed |
| US-20250388653-A1 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | ADIMAB LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250313612-A1 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | ADIMAB LLC (US) | 2025-10-09 | — | — | US | disclosed |
| US-12281156-B2 | Anti-respiratory syncytial virus antibodies, and methods of their generation and use | ADIMAB, LLC (US) | 2025-04-22 | — | — | US | disclosed |
| CN-119812526-A | Composite solid electrolyte and preparation method and application thereof | 深圳市德方创域新能源科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| WO-2024173657-A9 | ANTIBODIES TO HUMAN PNEUMOVIRUSES AND METHODS OF USE THEREFOR | VANDERBILT UNIVERSITY (US) | 2025-02-27 | — | — | WO | disclosed |
| US-12215141-B2 | Anti-respiratory syncytial virus antibodies, and methods of their generation and use | ADIMAB, LLC (US) | 2025-02-04 | — | — | US | disclosed |
| CN-119027804-A | Alfalfa weed detection method and system based on lightweight balance feature fusion | 宁夏大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-118931471-A | Flame-retardant UV-cured high-adhesive pressure-sensitive adhesive and preparation method thereof | 广东正浩交通技术有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118921766-A | Communication method, device, system, chip, medium and program product | 华为技术有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-11379705-B2 | System and computer-based method for simulating a human-like control behaviour in an environmental context | TOYOTA MOTOR EUROPE (BE) | 2022-07-05 | — | — | US | disclosed |
| EP-4003508-A1 | PERFUSION MODULATED TUMOR DOSE SCULPTING WITH SINGLE DOSE RADIOTHERAPY | Memorial Sloan Kettering Cancer Center (US) | 2022-06-01 | — | — | EP | disclosed |
| US-20220144922-A1 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | GATES MEDICAL RESEARCH INSTITUTE | 2022-05-12 | — | — | US | disclosed |
| US-11312761-B2 | Anti-respiratory syncytial virus antibodies, and methods of their generation and use | ADIMAB, LLC (US) | 2022-04-26 | — | — | US | disclosed |
| EP-3974447-A2 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | Adimab, LLC (US) | 2022-03-30 | — | — | EP | disclosed |
| EP-0532120-B1 | Process for the preparation of 4-hydroxy-3(2H)furanones | TASTEMAKER BV (NL) | 1998-01-07 | — | — | EP | disclosed |
| EP-0532120-A1 | Process for the preparation of 4-hydroxy-3(2H)furanones | Tastemaker B.V. (NL) | 1993-03-17 | — | — | EP | disclosed |
| EP-0008358-B1 | BIS-EPOXY-DIALKOXY ALKANES, THEIR PREPARATION AND THEIR USE | BASF Aktiengesellschaft (DE) | 1983-05-11 | — | — | EP | disclosed |
| US-4250101-A | Bis-epoxy-dialkoxy-alkanes | BASF AKTIENGESELLSCHAFT (DE) | 1981-02-10 | — | — | US | disclosed |
| EP-0008358-A1 | Bis-epoxy-dialkoxy alkanes, their preparation and their use | BASF Aktiengesellschaft (DE) | 1980-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388653-A1 | ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE | FCGR3B, VGF, FCGR2A | MAPT 4231/4885KDM4E 3561/4885TP53 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.